Price movement over the last 24 hours
Align Technology, Inc. vs iShares MSCI Indonesia ETF — how do they compare? Align Technology, Inc. trades at $175.71 (market cap $13.27B), while iShares MSCI Indonesia ETF trades at $11.7. The key difference: Align Technology, Inc. is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | EIDO | |
|---|---|---|
Market Cap | $13.27B | — |
Sector | Health | — |
52-Week High | $207.19 | $19.22 |
52-Week Low | $124.88 | $10.80 |
Enterprise Value | $12.32B | — |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
EIDO (iShares MSCI Indonesia ETF) trades at $11.81, up 3.14% today, but technical indicators show a bearish trend with selling pressure outweighing buying signals. The ETF faces headwinds from Indonesia's monetary policy tightening and dividend reductions, with key financial ratios currently unavailable for fundamental assessment. Recent news highlights Indonesia's economic initiatives including AI integration in government programs and reforestation efforts.
The outlook remains cautious as Bank Indonesia's rate hikes to defend the rupiah create currency volatility risks. While long-term GDP growth potential exists through government initiatives, near-term pressures from dividend cuts and technical bearishness suggest careful monitoring of Indonesian economic stability and ETF performance metrics is warranted for investors seeking emerging market exposure.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →